EMEA-002424-PIP02-19

Key facts

Active substance
7-(2-Methoxy-3,5-dimethylpyridin-4-yl)-1-[(3S)-tetrahydrofuran-3-yl]-1,5-dihydro-4H-pyrazolo[4,3-c]quinolin-4-one maleate
Therapeutic area
Neurology
Decision number
P/0354/2019
PIP number
EMEA-002424-PIP02-19
Pharmaceutical form(s)
Capsule, hard
Condition(s) / indication(s)
Treatment of dementia with Lewy bodies
Route(s) of administration
Oral use
Contact for public enquiries
Eisai Ltd

E-mail: lmedInfo@eisai.net
Tel. +44 2086001400

Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating